I have a lot of resources below to help you reach a higher protein and fiber intake
Quick Stats for Obesity GLP-1 Market Obesity GLP-1 Market Value (2025): USD 8,169 million Obesity GLP-1 Market Forecast Value (2035): USD 65,364 million Obesity GLP-1 Market Forecast CAGR: 23.1% Leading Molecule Class in Obesity GLP-1 Market: Semaglutide (58.0%) Key Growth Regions in Obesity GLP-1 Market: North America, Europe, and East Asia Top Key Players in Obesity GLP-1 Market: Novo Nordisk, Eli Lilly, and emerging manufacturers Between 2025 and 2030, the obesity GLP-1 market is projected to expand from USD 8169.0 million to USD 39,528 million, resulting in a value increase of USD 31359.0 million, which represents 54.8% of the total forecast growth for the decade
In the end, theres no one-size-fits-all when it comes to these medications
doi: 10.1111/1753-0407.13455 37 NaglKHermannJMPlamperMSchrderCDostAKordonouriOet al
GPs are bound by patient confidentiality and are there to support, not judge
doi:10.1111/dom.14725 Pi-Sunyer X, Astrup A, et al
